The More Life Company Corp. Announces Completion of Name Change From Mountain Valley MD Holdings Inc.
Subject to final processing by the Canadian Securities Exchange (the “CSE”), the Company expects its common shares to commence trading on the CSE under the new name and new trading symbol “MLCO” at the opening of trading on Thursday, August 20, 2026. The new CUSIP number for the Company’s common shares will be 616536108 and the new ISIN will be CA6165361081.
The Company’s common shares continue to be quoted on the OTCID under the trading symbol “MVMDF." The Company is in the process of completing the steps required to reflect the new corporate name and any related trading symbol change in
The Name Change reflects the evolution of the Company’s corporate identity and is intended to better align the Company’s brand with its current business focus, commercial objectives and future growth plans.
Dennis Hancock, President and Chief Executive Officer of the Company, stated: “We wanted a name that could be understood before it was explained. The More Life Company is fresh, clear and human, and directly connected to the value at the heart of our work. We named the Company for the outcome, not the chemistry. It allows our technologies and partnerships to be understood by the value they can deliver for the people and markets we serve. More Life is not simply a name. It is the standard we are working toward fulfilling. Life has more to give, and our purpose is to help unlock it.”
Coinciding with the Name Change, the Company has launched its new corporate website at www.themorelife.company. The website introduces The More Life Company brand and provides updated information regarding the Company’s technologies and areas of focus across agriculture and human health. It will serve as the Company’s primary digital destination for corporate news, investor information, technology updates and partnership inquiries. Investors should continue to refer to the Company’s filings on SEDAR+ for the Company’s official public disclosure record.
The share capital of the Company remains unchanged as a result of the Name Change. The Company does not expect that any action will be required by existing shareholders with respect to the Name Change.
In connection with the Name Change, the Company has also completed a continuance from the Business Corporations Act (
The Company’s business, assets, liabilities, management and operations remain unchanged as a result of the Name Change, continuance and short-form amalgamation.
SHAREHOLDER FAQ
Do shareholders need to take any action in connection with the Name Change?
No. Shareholders are not required to take any action in connection with the Name Change.
Will there be a consolidation, share exchange or change to shareholders’ ownership interests?
No. The Name Change is not being completed in connection with a consolidation, share exchange or other change to shareholders’ ownership interests.
Do existing share certificates or DRS statements need to be exchanged?
The Company does not expect that shareholders will be required to exchange existing share certificates or DRS statements solely as a result of the Name Change. Certificates representing common shares of the Company in its former name are expected to remain valid. If a shareholder’s broker, intermediary or the Company’s transfer agent requires any additional steps in connection with a future deposit, transfer or other transaction involving a certificate, those steps may be addressed at that time in the ordinary course.
Is the Name Change part of a merger, acquisition, reverse takeover or change of business?
No. The Name Change is being undertaken as part of the Company’s branding initiative and is not being completed in connection with a merger, acquisition, reverse takeover, change of business or other material strategic transaction.
ABOUT THE MORE LIFE COMPANY CORP.
The More Life Company Corp., formerly Mountain Valley MD Holdings Inc., is building a world-class organization centered around the implementation, licensing and reselling of key technologies and formulations:
- patented Quicksome™ oral formulation and delivery technologies;
- patented Quicksol™ solubility formulation technology; and
- licensed product reseller of Agrarius™, a novel agricultural plant signaling technology.
Consistent with its vision towards “More Life”, the Company applies its owned and licensed technologies to its work for advanced delivery of molecules for human and husbandry animal applications, including the development of products for pain management, weight loss, energy, focus, sleep, anxiety, and more. Additionally, the Company’s work with Agrarius is focused on generating a positive impact on crop yields and reducing fertilizer usage.
The Company’s patented Quicksome™ technology utilizes proprietary formulations and stabilizing molecules to encapsulate and formulate active ingredients into highly efficient product formats. The result is a new generation of product formulations that could be capable of delivering nutraceutical and drug molecules into the body faster, with greater impact, efficiency and accuracy.
The Company’s patented Quicksol™ technology covers all highly solubilized macrocyclic lactones that could be effectively applied in multiple viral applications that could positively impact human and animal health globally.
The Company’s licensed Agrarius™ agricultural plant signaling technology is designed to be applied to crops to naturally increase yields, reduce fertilizer usage, and increase general resilience to pests and climate change.
For more Company information and contact details, visit www.themorelife.company.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION
Certain statements contained in this news release may constitute forward-looking information within the meaning of applicable securities laws. Forward-looking information is often, but not always, identified by words such as “anticipate”, “believe”, “continue”, “estimate”, “expect”, “intend”, “may”, “plan”, “potential”, “should”, “will” and similar expressions, or statements that events, conditions or results “can”, “could”, “may”, “should” or “will” occur or be achieved.
The Company is making forward-looking statements with respect to the anticipated timing of the Name Change becoming effective for trading on the CSE and the anticipated timing of the Company’s new corporate name and trading symbol being reflected in the United States.
The anticipated effective trading dates and related trading symbol changes are subject to the timing and completion of applicable CSE, OTC Markets Group and other administrative processes and may differ from the dates currently expected by the Company. Although the Company believes that the expectations and assumptions reflected in the forward-looking information are reasonable as of the date hereof, forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause actual timing or results to differ materially from those expressed or implied by such forward-looking information.
Readers are cautioned not to place undue reliance on forward-looking information. Any forward-looking information contained in this news release represents the Company’s expectations as of the date hereof and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.
Neither the CSE nor OTC Markets Group has reviewed or approved the contents of this press release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260818475493/en/
For further information:
Dennis Hancock
President and Chief Executive Officer
The More Life Company Corp.
Investor Relations: 647-725-9755
Email: info@themorelife.company
Source: Mountain Valley MD Holdings Inc.